Laura Smalley will present at the AIPLA Chemical/Pharma Patent Practice Institute on, “Obviousness-Type Double Patenting and Chemical/Pharma Patents”, on May 20 from 1:30 – 2:15 PM.
A full description of the program is below:
AIPLA’s Chemical Practice & Biotechnology Committees present an Advanced Chemical/Pharma Patent Practice Institute on Friday, May 20, 2022, immediately following the AIPLA 2022 Spring Meeting in New Orleans. This advanced course teaches patent practitioners how they can use fundamentally sound but oft-overlooked principles to prepare and prosecute United States chemical/pharma patent applications to withstand both PTAB and district court challenges. While separate from the Spring Meeting, it presents a great opportunity to extend your stay in New Orleans!
The principles taught will greatly help those advanced chemical/pharma patent practitioners involved with pre-litigations, portfolio management, litigations, Orange Book listings, Purple Book/BCPIA, regulatory practice, due diligences, health checks, and analysis of third-party patents for validity/patentability, infringement, and enforceability issues, as well as for preparing IPR and/or PGR petitions and defending the patent against them.